10 20 30 40 50 60 70 80 1JCQ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 11-JUN-01 1JCQ
TITLE CRYSTAL STRUCTURE OF HUMAN PROTEIN FARNESYLTRANSFERASE TITLE 2 COMPLEXED WITH FARNESYL DIPHOSPHATE AND THE PEPTIDOMIMETIC TITLE 3 INHIBITOR L-739,750
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN FARNESYLTRANSFERASE, ALPHA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ALPHA SUBUNIT; COMPND 5 SYNONYM: CAAX FARNESYLTRANSFERASE ALPHA SUBUNIT; RAS COMPND 6 PROTEINS PRENYLTRANSFERASE ALPHA; FTASE-ALPHA; PRENYL- COMPND 7 PROTEIN TRANSFERASE RAM2 HOMOLOG; COMPND 8 EC: 2.5.1.-; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: PROTEIN FARNESYLTRANSFERASE, BETA SUBUNIT; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: BETA SUBUNIT; COMPND 15 SYNONYM: CAAX FARNESYLTRANSFERASE BETA SUBUNIT; RAS COMPND 16 PROTEINS PRENYLTRANSFERASE BETA; FTASE-BETA; PRENYL- COMPND 17 PROTEIN TRANSFERASE DPR1/RAM1 SUBUNIT; COMPND 18 EC: 2.5.1.-; COMPND 19 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS FTASE, PFT, PFTASE, FT, FPT, FARNESYLTRANSFERASE, FARNESYL KEYWDS 2 TRANSFERASE, FARNESYL PROTEIN TRANSFERASE, CAAX, RAS, KEYWDS 3 CANCER, TUMOR REGRESSION, L-739,750, PEPTIDOMIMETIC, KEYWDS 4 INHIBITOR
EXPDTA X-RAY DIFFRACTION
AUTHOR S.B.LONG,P.J.CASEY,L.S.BEESE
REVDAT 2 24-FEB-09 1JCQ 1 VERSN REVDAT 1 02-NOV-01 1JCQ 0
JRNL AUTH S.B.LONG,P.J.HANCOCK,A.M.KRAL,H.W.HELLINGA, JRNL AUTH 2 L.S.BEESE JRNL TITL THE CRYSTAL STRUCTURE OF HUMAN PROTEIN JRNL TITL 2 FARNESYLTRANSFERASE REVEALS THE BASIS FOR JRNL TITL 3 INHIBITION BY CAAX TETRAPEPTIDES AND THEIR JRNL TITL 4 MIMETICS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 12948 2001 JRNL REFN ISSN 0027-8424 JRNL PMID 11687658 JRNL DOI 10.1073/PNAS.241407898
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.B.LONG,P.J.CASEY,L.S.BEESE REMARK 1 TITL THE BASIS FOR K-RAS4B BINDING SPECIFICITY TO REMARK 1 TITL 2 PROTEIN FARNESYLTRANSFERASE REVEALED BY 2A REMARK 1 TITL 3 RESOLUTION TERNARY COMPLEX STRUCTURES REMARK 1 REF STRUCTURE V. 8 209 2000 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(00)00096-4 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.-W.PARK,S.R.BODULURI,J.F.MOOMAW,P.J.CASEY, REMARK 1 AUTH 2 L.S.BEESE REMARK 1 TITL CRYSTAL STRUCTURE OF PROTEIN FARNESYLTRANSFERASE REMARK 1 TITL 2 AT 2.25A RESOLUTION REMARK 1 REF SCIENCE V. 275 1800 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 1 DOI 10.1126/SCIENCE.275.5307.1800
REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 46863 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2341 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 69.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4305 REMARK 3 BIN R VALUE (WORKING SET) : 0.2500 REMARK 3 BIN FREE R VALUE : 0.2440 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 238 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5898 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 338 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.30 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.080 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.030 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.240 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PR REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : ACE REMARK 3 PARAMETER FILE 4 : FPP REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PR REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : ACE REMARK 3 TOPOLOGY FILE 4 : FPP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK 4 REMARK 4 1JCQ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUN-01. REMARK 100 THE RCSB ID CODE IS RCSB013630.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46302 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.5 REMARK 200 DATA REDUNDANCY : 5.590 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.95 REMARK 200 R MERGE FOR SHELL (I) : 0.19300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.130 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1D8D REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, AMMONIUM ACETATE, DTT, REMARK 280 TRIS-HCL, PH 5.7, VAPOR DIFFUSION, HANGING DROP AT 290K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.61400 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 43.22800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 32.42100 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 54.03500 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 10.80700 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT OF PROTEIN FARNESYLTRANSFERASE REMARK 300 (FTASE) IS A HETERODIMER OF ALPHA AND BETA SUBUNITS. THERE IS REMARK 300 ONE FTASE HETERODIMER PER ASYMMETRIC UNIT.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -70.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 VAL A 7 REMARK 465 GLY A 8 REMARK 465 GLU A 9 REMARK 465 ALA A 10 REMARK 465 ALA A 11 REMARK 465 GLN A 12 REMARK 465 GLY A 13 REMARK 465 GLY A 14 REMARK 465 GLU A 15 REMARK 465 PRO A 16 REMARK 465 GLY A 17 REMARK 465 GLN A 18 REMARK 465 PRO A 19 REMARK 465 ALA A 20 REMARK 465 GLN A 21 REMARK 465 PRO A 22 REMARK 465 PRO A 23 REMARK 465 PRO A 24 REMARK 465 GLN A 25 REMARK 465 PRO A 26 REMARK 465 HIS A 27 REMARK 465 PRO A 28 REMARK 465 PRO A 29 REMARK 465 PRO A 30 REMARK 465 PRO A 31 REMARK 465 GLN A 32 REMARK 465 GLN A 33 REMARK 465 GLN A 34 REMARK 465 HIS A 35 REMARK 465 LYS A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 MET A 39 REMARK 465 ALA A 40 REMARK 465 ALA A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 GLY A 44 REMARK 465 GLU A 45 REMARK 465 ALA A 46 REMARK 465 VAL A 47 REMARK 465 ALA A 48 REMARK 465 SER A 49 REMARK 465 PRO A 50 REMARK 465 MET A 51 REMARK 465 ASP A 52 REMARK 465 ASP A 53 REMARK 465 GLY A 54 REMARK 465 SER A 368 REMARK 465 THR A 369 REMARK 465 GLU A 370 REMARK 465 ASN A 371 REMARK 465 ASP A 372 REMARK 465 SER A 373 REMARK 465 PRO A 374 REMARK 465 THR A 375 REMARK 465 ASN A 376 REMARK 465 VAL A 377 REMARK 465 GLN A 378 REMARK 465 GLN A 379 REMARK 465 GLU A 380 REMARK 465 GLU A 381 REMARK 465 PHE A 382 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 PRO B 4 REMARK 465 SER B 5 REMARK 465 SER B 6 REMARK 465 PHE B 7 REMARK 465 THR B 8 REMARK 465 TYR B 9 REMARK 465 TYR B 10 REMARK 465 CYS B 11 REMARK 465 PRO B 12 REMARK 465 PRO B 13 REMARK 465 SER B 14 REMARK 465 GLU B 425 REMARK 465 LEU B 426 REMARK 465 LYS B 427 REMARK 465 ASP B 428 REMARK 465 GLU B 429 REMARK 465 THR B 430 REMARK 465 SER B 431 REMARK 465 ALA B 432 REMARK 465 GLU B 433 REMARK 465 PRO B 434 REMARK 465 ALA B 435 REMARK 465 THR B 436 REMARK 465 ASP B 437
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 308 CA - CB - CG ANGL. DEV. = -14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 71 0.09 -64.05 REMARK 500 VAL A 88 36.61 38.40 REMARK 500 LYS A 164 71.19 -102.32 REMARK 500 ALA A 197 -1.71 -58.77 REMARK 500 THR A 247 -89.88 -114.77 REMARK 500 HIS A 306 11.50 -147.81 REMARK 500 ASN A 325 43.55 -109.26 REMARK 500 GLU A 347 -61.81 -124.09 REMARK 500 ASP A 349 47.88 -157.96 REMARK 500 ASN B 65 -124.98 59.39 REMARK 500 GLN B 74 60.04 -64.45 REMARK 500 GLN B 318 31.20 -87.33 REMARK 500 SER B 326 -5.57 -149.89 REMARK 500 HIS B 383 113.80 -163.75 REMARK 500 PRO B 421 113.41 -36.90 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1248 DISTANCE = 14.96 ANGSTROMS REMARK 525 HOH A1447 DISTANCE = 14.19 ANGSTROMS REMARK 525 HOH B1637 DISTANCE = 6.83 ANGSTROMS REMARK 525 HOH B1638 DISTANCE = 7.06 ANGSTROMS
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 362 NE2 REMARK 620 2 739 B3012 SCC 100.4 REMARK 620 3 ASP B 297 OD1 79.8 150.2 REMARK 620 4 ASP B 297 OD2 115.8 102.3 53.3 REMARK 620 5 CYS B 299 SG 120.5 112.5 92.0 104.0 REMARK 620 N 1 2 3 4
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SUC B 3010 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FPP B 3011 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 739 B 3012 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 3002
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JCR RELATED DB: PDB REMARK 900 RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE NON- REMARK 900 SUBSTRATE TETRAPEPTIDE INHIBITOR CVFM AND FARNESYL REMARK 900 DIPHOSPHATE SUBSTRATE REMARK 900 RELATED ID: 1JCS RELATED DB: PDB REMARK 900 RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE PEPTIDE REMARK 900 SUBSTRATE TKCVFM AND AN ANALOG OF FARNESYL DIPHOSPHATE REMARK 900 RELATED ID: 1D8D RELATED DB: PDB REMARK 900 PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A K-RAS4B REMARK 900 PEPTIDE SUBSTRATE AND FARNESYL DIPHOSPHATE ANALOG REMARK 900 RELATED ID: 1FT1 RELATED DB: PDB REMARK 900 UNLIGANDED PROTEIN FARENESYLTRANSFERASE
DBREF 1JCQ A 1 379 UNP P49354 PFTA_HUMAN 1 379 DBREF 1JCQ B 1 437 UNP P49356 PFTB_HUMAN 1 437
SEQADV 1JCQ GLU A 380 UNP P49354 INSERTION SEQADV 1JCQ GLU A 381 UNP P49354 INSERTION SEQADV 1JCQ PHE A 382 UNP P49354 INSERTION
SEQRES 1 A 382 MET ALA ALA THR GLU GLY VAL GLY GLU ALA ALA GLN GLY SEQRES 2 A 382 GLY GLU PRO GLY GLN PRO ALA GLN PRO PRO PRO GLN PRO SEQRES 3 A 382 HIS PRO PRO PRO PRO GLN GLN GLN HIS LYS GLU GLU MET SEQRES 4 A 382 ALA ALA GLU ALA GLY GLU ALA VAL ALA SER PRO MET ASP SEQRES 5 A 382 ASP GLY PHE VAL SER LEU ASP SER PRO SER TYR VAL LEU SEQRES 6 A 382 TYR ARG ASP ARG ALA GLU TRP ALA ASP ILE ASP PRO VAL SEQRES 7 A 382 PRO GLN ASN ASP GLY PRO ASN PRO VAL VAL GLN ILE ILE SEQRES 8 A 382 TYR SER ASP LYS PHE ARG ASP VAL TYR ASP TYR PHE ARG SEQRES 9 A 382 ALA VAL LEU GLN ARG ASP GLU ARG SER GLU ARG ALA PHE SEQRES 10 A 382 LYS LEU THR ARG ASP ALA ILE GLU LEU ASN ALA ALA ASN SEQRES 11 A 382 TYR THR VAL TRP HIS PHE ARG ARG VAL LEU LEU LYS SER SEQRES 12 A 382 LEU GLN LYS ASP LEU HIS GLU GLU MET ASN TYR ILE THR SEQRES 13 A 382 ALA ILE ILE GLU GLU GLN PRO LYS ASN TYR GLN VAL TRP SEQRES 14 A 382 HIS HIS ARG ARG VAL LEU VAL GLU TRP LEU ARG ASP PRO SEQRES 15 A 382 SER GLN GLU LEU GLU PHE ILE ALA ASP ILE LEU ASN GLN SEQRES 16 A 382 ASP ALA LYS ASN TYR HIS ALA TRP GLN HIS ARG GLN TRP SEQRES 17 A 382 VAL ILE GLN GLU PHE LYS LEU TRP ASP ASN GLU LEU GLN SEQRES 18 A 382 TYR VAL ASP GLN LEU LEU LYS GLU ASP VAL ARG ASN ASN SEQRES 19 A 382 SER VAL TRP ASN GLN ARG TYR PHE VAL ILE SER ASN THR SEQRES 20 A 382 THR GLY TYR ASN ASP ARG ALA VAL LEU GLU ARG GLU VAL SEQRES 21 A 382 GLN TYR THR LEU GLU MET ILE LYS LEU VAL PRO HIS ASN SEQRES 22 A 382 GLU SER ALA TRP ASN TYR LEU LYS GLY ILE LEU GLN ASP SEQRES 23 A 382 ARG GLY LEU SER LYS TYR PRO ASN LEU LEU ASN GLN LEU SEQRES 24 A 382 LEU ASP LEU GLN PRO SER HIS SER SER PRO TYR LEU ILE SEQRES 25 A 382 ALA PHE LEU VAL ASP ILE TYR GLU ASP MET LEU GLU ASN SEQRES 26 A 382 GLN CYS ASP ASN LYS GLU ASP ILE LEU ASN LYS ALA LEU SEQRES 27 A 382 GLU LEU CYS GLU ILE LEU ALA LYS GLU LYS ASP THR ILE SEQRES 28 A 382 ARG LYS GLU TYR TRP ARG TYR ILE GLY ARG SER LEU GLN SEQRES 29 A 382 SER LYS HIS SER THR GLU ASN ASP SER PRO THR ASN VAL SEQRES 30 A 382 GLN GLN GLU GLU PHE SEQRES 1 B 437 MET ALA SER PRO SER SER PHE THR TYR TYR CYS PRO PRO SEQRES 2 B 437 SER SER SER PRO VAL TRP SER GLU PRO LEU TYR SER LEU SEQRES 3 B 437 ARG PRO GLU HIS ALA ARG GLU ARG LEU GLN ASP ASP SER SEQRES 4 B 437 VAL GLU THR VAL THR SER ILE GLU GLN ALA LYS VAL GLU SEQRES 5 B 437 GLU LYS ILE GLN GLU VAL PHE SER SER TYR LYS PHE ASN SEQRES 6 B 437 HIS LEU VAL PRO ARG LEU VAL LEU GLN ARG GLU LYS HIS SEQRES 7 B 437 PHE HIS TYR LEU LYS ARG GLY LEU ARG GLN LEU THR ASP SEQRES 8 B 437 ALA TYR GLU CYS LEU ASP ALA SER ARG PRO TRP LEU CYS SEQRES 9 B 437 TYR TRP ILE LEU HIS SER LEU GLU LEU LEU ASP GLU PRO SEQRES 10 B 437 ILE PRO GLN ILE VAL ALA THR ASP VAL CYS GLN PHE LEU SEQRES 11 B 437 GLU LEU CYS GLN SER PRO GLU GLY GLY PHE GLY GLY GLY SEQRES 12 B 437 PRO GLY GLN TYR PRO HIS LEU ALA PRO THR TYR ALA ALA SEQRES 13 B 437 VAL ASN ALA LEU CYS ILE ILE GLY THR GLU GLU ALA TYR SEQRES 14 B 437 ASP ILE ILE ASN ARG GLU LYS LEU LEU GLN TYR LEU TYR SEQRES 15 B 437 SER LEU LYS GLN PRO ASP GLY SER PHE LEU MET HIS VAL SEQRES 16 B 437 GLY GLY GLU VAL ASP VAL ARG SER ALA TYR CYS ALA ALA SEQRES 17 B 437 SER VAL ALA SER LEU THR ASN ILE ILE THR PRO ASP LEU SEQRES 18 B 437 PHE GLU GLY THR ALA GLU TRP ILE ALA ARG CYS GLN ASN SEQRES 19 B 437 TRP GLU GLY GLY ILE GLY GLY VAL PRO GLY MET GLU ALA SEQRES 20 B 437 HIS GLY GLY TYR THR PHE CYS GLY LEU ALA ALA LEU VAL SEQRES 21 B 437 ILE LEU LYS ARG GLU ARG SER LEU ASN LEU LYS SER LEU SEQRES 22 B 437 LEU GLN TRP VAL THR SER ARG GLN MET ARG PHE GLU GLY SEQRES 23 B 437 GLY PHE GLN GLY ARG CYS ASN LYS LEU VAL ASP GLY CYS SEQRES 24 B 437 TYR SER PHE TRP GLN ALA GLY LEU LEU PRO LEU LEU HIS SEQRES 25 B 437 ARG ALA LEU HIS ALA GLN GLY ASP PRO ALA LEU SER MET SEQRES 26 B 437 SER HIS TRP MET PHE HIS GLN GLN ALA LEU GLN GLU TYR SEQRES 27 B 437 ILE LEU MET CYS CYS GLN CYS PRO ALA GLY GLY LEU LEU SEQRES 28 B 437 ASP LYS PRO GLY LYS SER ARG ASP PHE TYR HIS THR CYS SEQRES 29 B 437 TYR CYS LEU SER GLY LEU SER ILE ALA GLN HIS PHE GLY SEQRES 30 B 437 SER GLY ALA MET LEU HIS ASP VAL VAL LEU GLY VAL PRO SEQRES 31 B 437 GLU ASN ALA LEU GLN PRO THR HIS PRO VAL TYR ASN ILE SEQRES 32 B 437 GLY PRO ASP LYS VAL ILE GLN ALA THR THR TYR PHE LEU SEQRES 33 B 437 GLN LYS PRO VAL PRO GLY PHE GLU GLU LEU LYS ASP GLU SEQRES 34 B 437 THR SER ALA GLU PRO ALA THR ASP
HET SUC B3010 23 HET ZN B1001 1 HET FPP B3011 24 HET 739 B3012 34 HET ACY A3002 4
HETNAM SUC SUCROSE HETNAM ZN ZINC ION HETNAM FPP FARNESYL DIPHOSPHATE HETNAM 739 2(S)-{2(S)-[2(R)-AMINO-3-MERCAPTO]PROPYLAMINO-3(S)- HETNAM 2 739 METHYL}PENTYLOXY-3-PHENYLPROPIONYLMETHIONINE SULFONE HETNAM ACY ACETIC ACID
HETSYN 739 L-739,750
FORMUL 3 SUC C12 H22 O11 FORMUL 4 ZN ZN 2+ FORMUL 5 FPP C15 H28 O7 P2 FORMUL 6 739 C23 H39 N3 O6 S2 FORMUL 7 ACY C2 H4 O2 FORMUL 8 HOH *334(H2 O)
HELIX 1 1 LEU A 65 ARG A 69 5 5 HELIX 2 2 ARG A 69 ALA A 73 5 5 HELIX 3 3 SER A 93 ASP A 110 1 18 HELIX 4 4 SER A 113 ASN A 127 1 15 HELIX 5 5 ASN A 130 LEU A 144 1 15 HELIX 6 6 ASP A 147 GLN A 162 1 16 HELIX 7 7 ASN A 165 ARG A 180 1 16 HELIX 8 8 GLN A 184 ASP A 196 1 13 HELIX 9 9 ASN A 199 PHE A 213 1 15 HELIX 10 10 ASN A 218 ASP A 230 1 13 HELIX 11 11 ASN A 233 THR A 247 1 15 HELIX 12 12 ASP A 252 VAL A 270 1 19 HELIX 13 13 ASN A 273 GLN A 285 1 13 HELIX 14 14 GLY A 288 LYS A 291 5 4 HELIX 15 15 TYR A 292 SER A 307 1 16 HELIX 16 16 SER A 308 ASN A 325 1 18 HELIX 17 17 ASN A 329 GLU A 347 1 19 HELIX 18 18 ASP A 349 ILE A 351 5 3 HELIX 19 19 ARG A 352 HIS A 367 1 16 HELIX 20 20 LEU B 23 ARG B 27 5 5 HELIX 21 21 ARG B 27 ARG B 34 5 8 HELIX 22 22 THR B 42 SER B 61 1 20 HELIX 23 23 GLN B 74 LEU B 86 1 13 HELIX 24 24 THR B 90 ASP B 97 5 8 HELIX 25 25 SER B 99 LEU B 114 1 16 HELIX 26 26 PRO B 119 GLN B 134 1 16 HELIX 27 27 HIS B 149 GLY B 164 1 16 HELIX 28 28 THR B 165 ILE B 172 1 8 HELIX 29 29 ASN B 173 LYS B 185 1 13 HELIX 30 30 ASP B 200 THR B 214 1 15 HELIX 31 31 GLY B 224 GLN B 233 1 10 HELIX 32 32 HIS B 248 LEU B 262 1 15 HELIX 33 33 ARG B 264 LEU B 268 5 5 HELIX 34 34 ASN B 269 ARG B 280 1 12 HELIX 35 35 CYS B 299 GLN B 304 1 6 HELIX 36 36 GLY B 306 GLN B 318 1 13 HELIX 37 37 HIS B 331 CYS B 343 1 13 HELIX 38 38 ASP B 359 GLN B 374 1 16 HELIX 39 39 VAL B 389 ALA B 393 5 5 HELIX 40 40 GLY B 404 GLN B 417 1 14
SHEET 1 A 2 GLN A 89 ILE A 90 0 SHEET 2 A 2 GLN B 88 LEU B 89 1 N LEU B 89 O GLN A 89 SHEET 1 B 2 HIS B 375 SER B 378 0 SHEET 2 B 2 MET B 381 ASP B 384 -1 O MET B 381 N SER B 378
LINK ZN ZN B1001 NE2 HIS B 362 1555 1555 2.34 LINK ZN ZN B1001 SCC 739 B3012 1555 1555 2.36 LINK ZN ZN B1001 OD1 ASP B 297 1555 1555 2.67 LINK ZN ZN B1001 OD2 ASP B 297 1555 1555 1.97 LINK ZN ZN B1001 SG CYS B 299 1555 1555 2.29
SITE 1 AC1 14 TYR A 241 GLN A 285 ASP A 286 ALA B 230 SITE 2 AC1 14 ARG B 231 GLN B 233 ASN B 234 TRP B 235 SITE 3 AC1 14 GLY B 237 ASN B 269 SER B 272 HOH B1395 SITE 4 AC1 14 HOH B1424 HOH B1517 SITE 1 AC2 4 ASP B 297 CYS B 299 HIS B 362 739 B3012 SITE 1 AC3 18 LYS A 164 TYR A 166 HIS B 248 GLY B 250 SITE 2 AC3 18 TYR B 251 CYS B 254 ARG B 291 LYS B 294 SITE 3 AC3 18 TYR B 300 TRP B 303 TYR B 361 HOH B1162 SITE 4 AC3 18 HOH B1165 HOH B1245 HOH B1677 HOH B1684 SITE 5 AC3 18 HOH B1686 739 B3012 SITE 1 AC4 21 TYR A 131 LYS A 164 TYR A 166 GLN A 167 SITE 2 AC4 21 HIS A 201 HOH A1310 ALA B 98 SER B 99 SITE 3 AC4 21 TRP B 102 TRP B 106 ALA B 151 PRO B 152 SITE 4 AC4 21 ARG B 202 ASP B 297 CYS B 299 TYR B 300 SITE 5 AC4 21 HIS B 362 ZN B1001 HOH B1163 HOH B1312 SITE 6 AC4 21 FPP B3011 SITE 1 AC5 8 TRP A 169 HIS A 170 ARG A 173 GLN A 204 SITE 2 AC5 8 HOH A1115 HOH A1171 HOH A1315 GLU B 198
CRYST1 178.476 178.476 64.842 90.00 90.00 120.00 P 61 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.005603 0.003235 0.000000 0.00000
SCALE2 0.000000 0.006470 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015422 0.00000